Over 1.6 million urological procedures will be performed by 2020 in Europe, this includes stone management, interventional BPH and nephrostomy procedures.
Vancouver, BC (PRWEB) September 02, 2014
According to a new report by iData Research (http://www.idataresearch.com), the leading global authority in medical device market research, the European urological device market is expected to grow to over €2 billion in 2020. Growth will be fueled by an increase in the number of procedures for the treatment of BPH, nephrostomy, urinary and kidney stones. This market includes TURP devices, laser BPH devices, brachytherapy, urinary catheters, nephrostomy devices, urinary incontinence slings, stone treatment devices, urological endoscopes and erectile dysfunction devices.
Fastest growing market is urological endoscopes which comprise of cystoscopes for endoscopy of the urinary bladder, ureteroscopes for examining the ureter, resectoscopes used in transurethral resection of the prostate (TURP) and nephroscopes used to examine the kidneys. Growth in this market will be sustained by the range of procedures that require the use of urological endoscopes. It is estimated that over 1.6 million urological procedures will be performed in Europe by 2020.
Players driving the European urological device market are Coloplast, a prominent player in the markets for nephrostomy devices, urinary incontinence slings, stone treatment devices and erectile dysfunction devices as well as, Wellspect HealthCare, Teleflex, C. R. Bard and Olympus.
Other key findings from the European Urological Device Market Report:
The number of TURP procedures continued to overshadow the number of laser BPH procedures in the treatment of benign prostate hyperplasia. The procedure is nearly as effective as open prostatectomy, but has a lower risk of serious complications such as blood loss, incontinence and impotence.
Growth of the brachytherapy market in Europe will vary by country, with some experiencing a contraction of the market and others experiencing an expansion. The largest percentage of brachytherapy procedures performed are in Germany. Procedures performed in France, the United Kingdom and Italy were also relatively large, although they all experienced moderate declines in procedural volumes.
The nephrostomy device market is dominated by the percutaneous nephrostomy set and balloon dilator segments. Sustained growth in these two segments will drive overall market expansion through 2020.
For Further Information
The global report series on the Markets for Urological Devices covers the U.S., Canada, 15 counties in Europe, Japan, India and China. The full reports provide a comprehensive analysis including procedure numbers, units sold, market value, forecasts, as well as a detailed competitive market shares and analysis of major players’ success strategies in each market and segment.
The reports cover devices used in the treatment of benign prostate hyperplasia (BPH), prostate cancer, and urinary incontinence as well as urinary and kidney stones. Other markets analyzed include urological endoscopes, urodynamic equipment and nephrostomy devices.
Get your free synopsis of the European urological device market report.
About iData Research
iData Research (http://www.idataresearch.com) is an international market research and consulting group focused on providing market intelligence for medical device and pharmaceutical companies. iData covers research in: Diabetes Drugs, Diabetes Devices, Pharmaceuticals, Anesthesiology, Wound Management, Orthopedics, Cardiovascular, Ophthalmics, Endoscopy, Gynecology, Urology and more.